Advertisement
Adding chemotherapy to radiation treatment may add years to the lives of patients with grade 2 gliomas

Adding Chemo May Prolong Lives of Some Grade 2 Glioma Patients

0
Those with slow-growing gliomas lived five years longer, on average, than those who got only radiation
A stimulant banned from competitive sports

Sport-Banned Oxilofrine Found in Diet Supplements

0
FDA has warned makers of 8 products containing oxilofrine, or methylsynephrine
For patients with worsening heart failure

Diuretic Dose Not Linked to Outcome in Heart Failure

0
In multivariate analysis, no correlation seen for patients with worsening heart failure
For patients with primary hyperparathyroidism

Surgery Cuts Fracture Risk in Primary Hyperparathyroidism

0
Reduced fracture risk for surgery; bisphosphonate treatment no better than observation
Expert consensus guidance has been issued regarding the use of non-statin therapies to lower cholesterol in high-risk patients. The consensus document was published online April 1 in the Journal of the American College of Cardiology to coincide with presentation at the annual meeting of the American College of Cardiology

ACC: Expert Guidance Issued for Use of Non-Statin Therapies

0
Authors recommend addition of ezetimibe at 10 mg/day for higher-risk patients
The price of insulin has tripled in only 10 years

Cost of Insulin Found to Have Tripled Over Past Decade

0
Since 2010, per-person costs topped spending on all other diabetes drugs combined
Diabetes medications containing saxagliptin and alogliptin may raise the risk of heart failure

FDA Issues New Warning for Two Diabetes Medications

0
Drugs containing saxagliptin or alogliptin may be linked to heart failure risk
Hydromorphone may be another treatment option for heroin addiction

Hydromorphone May Be New Treatment for Heroin Addiction

0
Researchers find hydromorphone an effective, widely available, licensed choice
The U.S. Food and Drug Administration has approved its second-ever "biosimilar" drug

FDA Approves Inflectra as ‘Biosimilar’ to Remicade

0
For adults with Crohn's, rheumatoid arthritis, or psoriasis
For patients with new-onset postoperative atrial fibrillation

ACC: Rate, Rhythm Control Both Effective for Post-Op A-Fib

0
Equal number of days of hospitalization, similar complication and persistent a-fib rates